The trajectory of the erectile dysfunction drug presents a complex picture for investors. While the initial release generated significant returns, the expiration of its patent opened the floodgates to cheaper https://elodieoriq800269.blogdun.com/42518404/sildenafil-and-big-pharma-a-precarious-opportunity